$0.000001
At close: Dec 12, 12:09 PM EDT
Comments
Loading...
Igene Biotechnology Analyst Ratings and Price Targets | OTC:IGNE | Benzinga
Igene Biotechnology Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Igene Biotechnology Corp from these most-recent analyst ratings.
Analyst Ratings for Igene Biotechnology
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Igene Biotechnology (IGNE) stock?
There is no price target for Igene Biotechnology
What is the most recent analyst rating for Igene Biotechnology (IGNE)?
There is no analyst for Igene Biotechnology
When was the last upgrade for Igene Biotechnology (IGNE)?
There is no last upgrade for Igene Biotechnology
When was the last downgrade for Igene Biotechnology (IGNE)?
There is no last downgrade for Igene Biotechnology.
When is the next analyst rating going to be posted or updated for Igene Biotechnology (IGNE)?
There is no next analyst rating for Igene Biotechnology.
Is the Analyst Rating Igene Biotechnology (IGNE) correct?
There is no next analyst rating for Igene Biotechnology.
Browse analyst ratings and price targets on all stocks.
